Chinese AI Chip Firm Biren Jumps 82% in HK IPO Debut

Shanghai Biren Technology's shares surged 82.1% in their Hong Kong debut, raising HK$5.58 billion. The listing signals a strong start for AI and semiconductor offerings in 2026. Read more on the implications for China's tech self-sufficiency drive.

Hyundai hikes car prices, Maruti Suzuki waits 15-20 days

Hyundai India announced a 0.6% average price hike across all models due to rising commodity costs. Market leader Maruti Suzuki will decide on its pricing strategy in 15-20 days. Read more for details on other automakers' price adjustments.

Lucknow-Kanpur Expressway faces 3-month delay

The 63-km Lucknow-Kanpur Expressway completion is delayed by 3 months for shifting a 400-kV power line. Once ready, travel time will drop from 120 to 70 minutes. Read details.

Gig Worker Strikes Highlight Need for Fair Treatment

Recent strikes by Swiggy, Zomato & Zepto workers against 10-minute delivery demand fair pay & safety. With gig workers projected to hit 23.5 million by 2030, companies must address their concerns. Read more.

Gold Prices Ease on MCX, Global Markets Cautious

Gold futures on MCX closed marginally lower at ₹135,690 per 10 grams. Experts analyze the cautious trend and the key factors that will drive bullion prices in 2026. Read the full outlook here.

India Rice Export Prices Reach 3-Month Peak

India's rice export prices surge to a near three-month high of $360 per ton. Bangladesh approves 50,000-ton import from India. Global demand remains weak. Get the full market analysis.

Bitcoin's 2026 Fall: US Reserve Policy & Gold's Rise

Bitcoin fell over 30% from its 2025 peak by Jan 2026, disappointed by US strategic reserve policy. Meanwhile, gold surged 63%. Explore the factors behind crypto's slump and gold's safe-haven appeal.

Jan 2 Bank Holiday: Check City-Wise List for New Year

Banks in Aizawl, Kochi, and Thiruvananthapuram are closed on January 2, 2026, for New Year Celebrations/Mannam Jayanthi. Check the full city-wise operational status and available digital banking services.

5 Breakout Stocks to Buy as Markets Consolidate on Jan 1

Sensex and Nifty ended mixed on the first trading day of 2026. Expert Sumeet Bagadia shares technical outlook and recommends five breakout stocks to buy, including Prataap Snacks and NTPC. Read for targets and analysis.

Gold Loans Surge 125%, Driving New Bank Credit

Gold loans in India surge 125% YoY, contributing 12% of new bank credit. Discover how rising gold prices and a shift to secured lending are reshaping the banking sector's portfolio.

Silver Futures Lose Momentum on MCX

Silver futures on MCX closed subdued, down nearly ₹19,000 from December's peak. Expert outlook remains bullish long-term. Track live updates on silver price trends.

The Truth Behind the Global Affordability Crisis

Voters in rich nations are angry about prices, but is there a real affordability crisis? We examine the data, the political rhetoric, and the risks of misguided policies. Read more.

Stock Market Mixed on Jan 1, 2026; Nifty Up 0.06%

Indian stock market indices closed mixed on January 1, 2026. Nifty 50 rose 0.06% to 26,146.55, while Sensex fell 0.04%. Analysts cite FII outflows, await Q3 earnings and budget cues. Get expert stock picks and gold outlook.

JSW, Mahindra consider REEVs if India's EV policy widens

JSW Motors and Mahindra & Mahindra express openness to range-extended electric vehicles (REEVs) if government incentives expand beyond pure EVs, even as experts debate the transitional technology's role. Read more.

₹10 Trillion Capex: Why It's Not a Broad Revival

New project announcements hit ₹10 trillion in Q3 FY26, but growth is concentrated in power & services. Manufacturing lags, and government spending remains weak. Read the full analysis.

Stock Picks for 2 Jan: Fedbank & Adani Energy

MarketSmith India recommends Fedbank Financial & Adani Energy Solutions. Get expert analysis, target prices, and key risks as Indian markets start 2026 on a muted note.

Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Page 2 of 437